Back to Journals » Lung Cancer: Targets and Therapy » Volume 8
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
7,254 | Dovepress* | 6,612+ | 1,180 | 7,792 | |
PubMed Central* | 642 | 244 | 886 | ||
Totals | 7,254 | 1,424 | 8,678 | ||
*Since 6 November 2017 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
2 | 0 | 0 | 1 | 0 | 1 |
View citations on PubMed and Google Scholar